Production of astatine-211-labeled radiopharmaceuticals
Properties and applications of astatine in nuclear medicine
Research and innovation REF: IN225 V1
Production of astatine-211-labeled radiopharmaceuticals
Properties and applications of astatine in nuclear medicine

Author : François GUÉRARD

Publication date: November 10, 2018 | Lire en français

Logo Techniques de l'Ingenieur You do not have access to this resource.
Request your free trial access! Free trial

Already subscribed?

3. Production of astatine-211-labeled radiopharmaceuticals

3.1 Radiolabeling chemistry with astatine-211

It was soon observed that the radiochemical synthesis methods classically used to radiolabel compounds with iodine radioisotopes could also be employed with astatine, in particular for the formation of carbon-halogen bonds. Radiolabeling approaches involving the formation of an astate-carbon covalent bond have enabled the creation of many compounds of interest for 211 At delivery. However, because the stability of this binding mode is sometimes insufficient, investigations are underway to propose more suitable alternatives for future use in patients.

You do not have access to this resource.
Logo Techniques de l'Ingenieur

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource. Click here to request your free trial access!

Already subscribed?

Ongoing reading
Production of astatine-211-labeled radiopharmaceuticals

Article included in this offer

"Healthcare technologies"

( 122 articles )

Complete knowledge base

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

View offer details
Contact our team FAQ